These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16178890)

  • 41. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
    Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
    J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background.
    Tajima Y; Yamazaki K; Makino R; Nishino N; Aoki S; Kato M; Morohara K; Kaetsu T; Kusano M
    Clin Cancer Res; 2006 Nov; 12(21):6469-79. PubMed ID: 17085661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinicopathological study on minute- and small-gastric cancer--growing pattern in incipient phase of gastric cancer development and its clinical significance].
    Sugawara T; Ouchi A; Shimizu F
    Nihon Geka Gakkai Zasshi; 1986 Oct; 87(10):1313-23. PubMed ID: 3796577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical value of routine haematoxylin-eosin stain in diagnosing submucosal lymphatic vessel infiltration in early gastric cancer].
    Yang QM; Zhu ZG; Kawamura T; Bando E; Yonemura Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):447-9. PubMed ID: 17851786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathological evaluation of biological behavior of submucosal invasive gastric carcinomas: relationship among lymph node metastasis, mucin phenotype and proliferative activity.
    Nakamoto J; Torisu R; Aoki R; Kimura Y; Yasuda M; Shiota K; Yamamoto Y; Ito S
    J Med Invest; 2007 Feb; 54(1-2):99-108. PubMed ID: 17380020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
    Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
    Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between mucin expression of gastric intramucosal signet ring cell carcinoma and its background mucosa.
    Seki T; Ito T; Kawachi H; Sekine M; Funata N; Takizawa T
    J Med Dent Sci; 2009 Mar; 56(1):25-35. PubMed ID: 19697516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endoscopic and clinicopathological features of intramucosal, histologically mixed-type, low-grade, well-differentiated gastric tubular adenocarcinoma with the potential for late-onset lymph node metastasis.
    Saitoh T; Takamura A; Watanabe G
    BMC Gastroenterol; 2018 Dec; 18(1):189. PubMed ID: 30587141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas.
    Kabashima A; Yao T; Sugimachi K; Tsuneyoshi M
    Histopathology; 2000 Dec; 37(6):513-22. PubMed ID: 11122433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The risk of lymph node metastasis in mucosal gastric carcinoma: especially for a mixture of differentiated and undifferentiated adenocarcinoma.
    Nakata K; Nagai E; Miyasaka Y; Ohuchida K; Ohtsuka T; Toma H; Hirahashi M; Aishima S; Oda Y; Tanaka M
    Hepatogastroenterology; 2012 Sep; 59(118):1855-8. PubMed ID: 22819904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
    Xiong ZF; Xiao H; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
    Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
    Oncology; 2001; 61(3):212-20. PubMed ID: 11574777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological features of undifferentiated mixed type early gastric cancer treated with endoscopic submucosal dissection.
    Iwamoto J; Mizokami Y; Ito M; Shomokobe K; Hirayama T; Honda A; Saito Y; Ikegami T; Matsuzaki Y
    Hepatogastroenterology; 2010; 57(97):185-90. PubMed ID: 20422899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical features.
    Yao T; Utsunomiya T; Oya M; Nishiyama K; Tsuneyoshi M
    World J Gastroenterol; 2006 Apr; 12(16):2510-6. PubMed ID: 16688795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer.
    Saito A; Shimoda T; Nakanishi Y; Ochiai A; Toda G
    Pathol Int; 2001 Mar; 51(3):165-71. PubMed ID: 11328531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.
    Shiratsu K; Higuchi K; Nakayama J
    Cancer Sci; 2014 Jan; 105(1):126-33. PubMed ID: 24138592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma.
    Ueyama H; Yao T; Nakashima Y; Hirakawa K; Oshiro Y; Hirahashi M; Iwashita A; Watanabe S
    Am J Surg Pathol; 2010 May; 34(5):609-19. PubMed ID: 20410811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "Crawling-type" adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma.
    Okamoto N; Kawachi H; Yoshida T; Kitagaki K; Sekine M; Kojima K; Kawano T; Eishi Y
    Gastric Cancer; 2013 Apr; 16(2):220-32. PubMed ID: 22865191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.